The change of RAMS' board and editorial team will de celebrated with drinks next wednesday, June 10th at 20:30 in café Piecken. At 21:00, we will introduce the new board and editorial staff. Also, this is the perfect opportunity to pick up one of the first copies of our brand-new second edition! Come and enjoy drinks with us, while meeting the new board. See you next week! … [Read more...]

We are proud to announce the new RAMS team 2015-2016. They will take over in July. Welcome! The Board Chair: Lars Gallée Vice-chair: Bas Vreugdenhil Treasurer: Barov Sanaan Public Relations: Audrey Hollanders Education: Sophie van Westendorp Editors-in-Chief David Wolthuis Cas van der Made Anna van Boekel Editors Kim Cortenbach, Jeroen Hol, Marije Kaan, Ellyze van Asbeck, Gerben Lassche, Bas ten Elzen, Jasper Maters, Shelley Dalloyaux, Ludo van de Linde, Jasper … [Read more...]

  Researchers of the Northeastern University in Boston found that breathing supplemental oxygen might help the treatment of cancer. They discovered that mice with lung cancer had a better rate of survival when breathing air with 60% of oxygen instead of the regular 21% of oxygen. Besides, the research showed that the 60%-O2 mice developed fewer metastases than the 21%-O2 mice. The researchers found that regulatory antitumor T-cells in an hypoxic environment were inactive. When … [Read more...]

RAMS, het nieuwe medisch-wetenschappelijke tijdschrift voor en door studenten van onze faculteit, zoekt nieuwe mensen voor het bestuur en redactie. Wil jij je steentje bijdragen aan dit initiatief? Dit is je kans!   Voor volgend collegejaar (augustus 2015 t/m juli 2016) zoeken we studenten voor de volgende functies:   Bestuurslid Public Relations Taakomschrijving: - Verantwoordelijk voor de promotie van RAMS - Bijhouden van social media - Updaten van de … [Read more...]

  Last week a research group from the university of Cincinnati published an article that suggests a better effectiveness of more expensive drugs than cheaper ones. At least, that was the perception of the participants of this Parkinson's disease study. In fact, a group of 12 patients used two formulations of the same placebo drug. They were told that one of the drugs was 100 dollar per dose and that the other drug was 1500 dollar per dose. Next to this, the participants were told that … [Read more...]